Singapore legislation

Regulation 37

of Healthcare Services (Assisted Reproduction Service) Regulations 2023

Regulation 37

When donor reproductive cells or embryos may be used

Amended byS 851/2023 wef 18/12/2023S 851/2023 wef 18/12/2023S 851/2023 wef 18/12/2023S 851/2023 wef 18/12/2023

Subregulation 1

Amended byS 851/2023 wef 18/12/2023S 851/2023 wef 18/12/2023

A licensee must not transfer into the body of a patient any embryo that —

(a)

was not created from an oocyte collected from the patient, unless —

(i)

the patient is unable to produce any viable oocytes for collection;

(ii)

the patient has had one or more unsuccessful attempts at the collection of viable oocytes; or

(iii)

a qualified assisted reproduction practitioner who is the licensee’s personnel is of the view that the likelihood of a foetus with no significant health condition or disability developing from any of the patient’s oocytes is low;

(b)

was not created from sperm collected from the patient’s husband, unless —

(i)

the patient’s husband is unable to produce viable sperm for fertilisation of an oocyte; or

(ii)

a qualified assisted reproduction practitioner who is the licensee’s personnel is of the view that the likelihood of a foetus with no significant health condition or disability developing from any of the patient’s husband’s sperm is low; or

(c)

is a consanguineous embryo.

Subregulation 2

Where a donor reproductive cell or donor embryo is used in the provision of an assisted reproduction service by a licensee to a patient, the licensee must ensure the following:

(a)

there is a clear set of criteria for the selection and acceptance of donors, which is documented;

(b)

donor sperm is accepted only from a man who is at least 21 years of age but below 41 years of age;

(c)

a donor oocyte is accepted only from a woman who is at least 21 years of age but below 38 years of age;

(d)

a donor embryo is accepted only where the embryo is created from an oocyte from a woman mentioned in sub‑paragraph (c).

Subregulation 3

Amended byS 851/2023 wef 18/12/2023S 851/2023 wef 18/12/2023

In this regulation —[Deleted by S 851/2023 wef 18/12/2023]

Definition

“consanguineous embryo” means an embryo created from —

(a)

an oocyte from a woman and sperm collected from a man who is the woman’s biological grandfather, father, uncle, brother, half‑brother, son, nephew or grandson; or

(b)

sperm collected from a man and an oocyte collected from a woman who is the man’s biological grandmother, mother, aunt, sister, half‑sister, daughter, niece or granddaughter;

Definition

“viable oocyte” means an oocyte that can result in the formation of an embryo;

Amended byS 851/2023 wef 18/12/2023

Definition

“viable sperm” means a sperm that can result in the formation of an embryo.

Amended byS 851/2023 wef 18/12/2023